Going with the flow: JAK-STAT signaling in JMML

Cancer Cell. 2008 Oct 7;14(4):279-80. doi: 10.1016/j.ccr.2008.09.006.

Abstract

Knowledge of the distinctive cellular and genetic traits of a cancer aids in diagnosis, prognosis, and potentially treatment. In this issue of Cancer Cell, Kotecha et al. (2008) demonstrate using a sophisticated flow cytometry approach that signal transduction responses to exogenous stimulation can inform diagnosis and pathobiology of myeloproliferative neoplasms.

Publication types

  • Comment
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / metabolism*
  • Cell Proliferation
  • Child
  • Disease Progression
  • Flow Cytometry*
  • Gene Expression Regulation, Neoplastic
  • Granulocyte-Macrophage Colony-Stimulating Factor / metabolism
  • Humans
  • Janus Kinase 2 / metabolism
  • Leukemia, Myelomonocytic, Juvenile / genetics
  • Leukemia, Myelomonocytic, Juvenile / metabolism*
  • Leukemia, Myelomonocytic, Juvenile / pathology
  • Leukemia, Myelomonocytic, Juvenile / therapy
  • Neoplasm Staging
  • Phosphorylation
  • STAT5 Transcription Factor / metabolism*
  • Signal Transduction* / genetics
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • STAT5 Transcription Factor
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • JAK2 protein, human
  • Janus Kinase 2